D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 59 Citations 14,751 107 World Ranking 1799 National Ranking 888
Medicine D-index 70 Citations 19,597 182 World Ranking 15849 National Ranking 8264

Overview

What is he best known for?

The fields of study he is best known for:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

His scientific interests lie mostly in Immunology, Internal medicine, Acquired immunodeficiency syndrome, Virology and Sida. His work in Immunology addresses issues such as Hazard ratio, which are connected to fields such as Adverse effect and Chemotherapy. The various areas that he examines in his Internal medicine study include Viral load and Zidovudine.

The Acquired immunodeficiency syndrome study combines topics in areas such as Viral disease and Incidence. Bernard Hirschel combines subjects such as Protease inhibitor and Epidemiology with his study of Virology. His Prospective cohort study study deals with Pharmacotherapy intersecting with Coinfection.

His most cited work include:

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (1019 citations)
  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study (857 citations)
  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. (804 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Viral load. In general Immunology study, his work on Viral disease, Viremia, CD8 and Immune system often relates to the realm of Institutional repository, thereby connecting several areas of interest. His Internal medicine research includes themes of Gastroenterology, Surgery and Zidovudine.

His Virology study combines topics from a wide range of disciplines, such as Reverse transcriptase, Antigen and Lymph. Sida is the focus of his Acquired immunodeficiency syndrome research. Bernard Hirschel has included themes like Reverse-transcriptase inhibitor, Pharmacotherapy, Combination therapy, Hazard ratio and Indinavir in his Viral load study.

He most often published in these fields:

  • Immunology (44.67%)
  • Internal medicine (43.65%)
  • Virology (26.90%)

What were the highlights of his more recent work (between 2008-2017)?

  • Immunology (44.67%)
  • Internal medicine (43.65%)
  • Virology (26.90%)

In recent papers he was focusing on the following fields of study:

His main research concerns Immunology, Internal medicine, Virology, Viral load and Cohort study. His Immunology research is multidisciplinary, relying on both Transmission, Acquired immunodeficiency syndrome, Antiretroviral therapy and Pediatrics. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.

The Virology study combines topics in areas such as Hiv infected, Lipodystrophy and Lipoatrophy. He combines subjects such as Interquartile range, Regimen, Tolerability, Combination therapy and Drug resistance with his study of Viral load. His Cohort study research is multidisciplinary, relying on both Body mass index, Pregnancy, Human herpes virus and Population study.

Between 2008 and 2017, his most popular works were:

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (1019 citations)
  • Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. (498 citations)
  • Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland (147 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His primary areas of investigation include Immunology, Internal medicine, Cohort study, Viral load and Transmission. His study in the field of Hepatitis C virus is also linked to topics like Neurocognitive. His Internal medicine research includes elements of Gastroenterology, Lopinavir and Surgery.

The concepts of his Cohort study study are interwoven with issues in Condom and Unprotected Sexual Intercourse. His studies deal with areas such as Quantitative trait locus, Viral evolution, Phylogenetics and Heritability as well as Viral load. His Transmission study also includes

  • Incidence which connect with Hygiene, Bathing, Intensive care medicine, Isolation and Clinical trial,
  • Molecular genetics that intertwine with fields like Virology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai.
Gastroenterology (2010)

1400 Citations

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob.
The Lancet (2000)

1209 Citations

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti.
The Lancet (1999)

1096 Citations

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.

Matthias Egger;Bernard Hirschel;Patrick Francioli;Philippe Sudre.
BMJ (1997)

904 Citations

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

Samanta Simioni;Matthias Cavassini;Jean Marie Annoni;Aline Rimbault Abraham.
AIDS (2009)

729 Citations

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Bruno Ledergerber;M. Egger;V. Erard;R. Weber.
JAMA (1999)

630 Citations

CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil.
JAMA Internal Medicine (2003)

498 Citations

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer.
The Lancet (2001)

461 Citations

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Gerd Fätkenheuer;Mark Nelson;Adriano Lazzarin;Irina Konourina.
The New England Journal of Medicine (2008)

415 Citations

Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen

Nicolas Sachsenberg;Alan S. Perelson;Sabine Yerly;Gérard A. Schockmel.
Journal of Experimental Medicine (1998)

379 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Bernard Hirschel

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 170

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 142

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 127

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 122

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 109

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 108

Bruno Ledergerber

Bruno Ledergerber

University of Zurich

Publications: 108

Rainer Weber

Rainer Weber

University of Zurich

Publications: 108

Hansjakob Furrer

Hansjakob Furrer

University of Bern

Publications: 107

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 104

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 101

Caroline Sabin

Caroline Sabin

University College London

Publications: 99

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 94

Sabine Yerly

Sabine Yerly

Geneva College

Publications: 86

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 85

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 83

Trending Scientists

Byron Cook

Byron Cook

Amazon (United States)

Sanjeev Khanna

Sanjeev Khanna

University of Pennsylvania

Robert B. McGhee

Robert B. McGhee

Naval Postgraduate School

David Lee Phillips

David Lee Phillips

University of Hong Kong

Tomas Tejero

Tomas Tejero

University of Zaragoza

Andrew G. Ewing

Andrew G. Ewing

University of Gothenburg

Francesco Regoli

Francesco Regoli

Marche Polytechnic University

Tong Wei

Tong Wei

China University of Petroleum, Beijing

Walter Gilbert

Walter Gilbert

Harvard University

Philip N. Benfey

Philip N. Benfey

Duke University

Bruno B. Andrade

Bruno B. Andrade

Oswaldo Cruz Foundation

Debbie S. Moskowitz

Debbie S. Moskowitz

McGill University

Donald G. MacKay

Donald G. MacKay

University of California, Los Angeles

Seock-Ah Im

Seock-Ah Im

Seoul National University Hospital

Sarah Pink

Sarah Pink

Monash University

S. A. Stanford

S. A. Stanford

University of California, Davis

Something went wrong. Please try again later.